Temsirolimus for Relapsed/Refractory Hodgkin's Lymphoma

Summary

This clinical trial is for patients with Hodgkin Lymphoma that has not responded to standard treatment. The purpose of this study is to determine what effects, good or bad, Temsirolimus has on Hodgkin Lymphoma. The study will also determine whether Temsirolimus is tolerated in patients with Hodgkin Lymphoma who have been previously treated with chemotherapy.

Timeline

Start

2009-01

Primary completion

2016-10

Completion

2017-10

Drugs

Indications